Taking genetic variation to the clinic

Our expertise is in understanding human genetic variability. Our strength is in our ability to identify crucial genetic differences and to make this information available to doctors and patients through robust, reliable diagnostic tests that improve health, prolong lives, and save money.

A disciplined approach

There are many treatment situations that can benefit from genetically based diagnostic tests. When deciding among these situations we focus on a variety of factors, including unmet medical needs, the scientific value and reliability of our data, and the recommendations of our Clinical Strategic Advisory Board (CSAB).

Working with Perlegen

We welcome collaborations with partners who share our goals.

More

A critical path through a complex world

Since the completion of the Human Genome Project, it has been clear that genetic variation is far more complex than previously imagined. Only by navigating through this complexity can we realize the benefits promised by the genetics revolution.

More

Company History

Perlegen was founded in 2001 as a spin-out from Affymetrix, a genetic tools company. For the first several years of its existence, until about 2004, Perlegen was focused on re-sequencing 50 human genomes, in order to map out the common elements of genetic diversity. During this time, Perlegen developed a majority of the content now publicly available in the “HapMap,” or human haplotype map.

More